Biodesix Inc [BDSX] stock is trading at $0.40, up 45.90%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BDSX shares have gain 79.59% over the last week, with a monthly amount drifted -19.37%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biodesix Inc [NASDAQ: BDSX] stock has seen the most recent analyst activity on May 14, 2025, when William Blair downgraded its rating to a Mkt Perform. On July 26, 2024, Craig Hallum initiated with a Buy rating and assigned a price target of $3 on the stock. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $2.80 on May 13, 2024. Lake Street initiated its recommendation with a Buy and recommended $3 as its price target on May 03, 2024. Morgan Stanley downgraded its rating to Equal-Weight for this stock on November 17, 2021, and downed its price target to $11. In a note dated November 23, 2020, William Blair initiated an Outperform rating.
Biodesix Inc [BDSX] stock has fluctuated between $0.17 and $2.04 over the past year. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Biodesix Inc [NASDAQ: BDSX] shares were valued at $0.40 at the most recent close of the market. An investor can expect a potential return of 650.0% based on the average BDSX price forecast.
Analyzing the BDSX fundamentals
Biodesix Inc [NASDAQ:BDSX] reported sales of 74.46M for the trailing twelve months, which represents a growth of 21.19%. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -0.44%, Pretax Profit Margin comes in at -0.54%, and Net Profit Margin reading is -0.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -1.68 and Total Capital is -0.45. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 5.63.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Biodesix Inc’s Current Ratio is 2.22. Also, the Quick Ratio is 2.14, while the Cash Ratio stands at 1.32. Considering the valuation of this stock, the price to sales ratio is 0.78, the price to book ratio is 5.23.
Transactions by insiders
Recent insider trading involved SCHULER JACK W, Director, that happened on May 16 ’25 when 4.0 million shares were purchased. Director, SCHULER JACK W completed a deal on May 19 ’25 to buy 0.72 million shares. Meanwhile, Chief Accounting Officer Vazquez Chris sold 112.0 shares on May 12 ’25.
